Health
Oxford covid vaccine: AstraZeneca denies trial subject had nerve ailment – Mint
Trials of the Oxford-Astra vaccine resumed in the UK over the weekend, after a pause to investigate the adverse event, while researchers in South Africa also restarted tests.But a big US trial of the vaccine is still on hold
AstraZeneca Plc, the drugmaker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in U.K. tests of the shot developed a rare nerve disease that might have signaled severe safety problems.AstraZeneca was responding Thursday to a CNN report citing documents indicating that the diagnosis of the participant was confirmed as transverse myelitis. The diagnosis was based on preliminary findings,” and is inaccurate, the Cambridge, England-based drugmaker …
-
General19 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General24 hours agoOlder Aussies back increased superannuation tax
-
Noosa News21 hours agoTips to improve engagement – Proctor
-
Noosa News21 hours agoPolice appeal for information over suspected link in torture and murder cases